Medullary thymic epithelial cell depletion leads to autoimmune hepatitis

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3510-3524

  Bonito, Anthony J ^a   Aloman, Costica ^b   Fiel, M Isabel ^a   Danzl, Nichole M ^c   Cha, Sungwon ^a   Weinstein, Erica G ^a   Jeong, Seihwan ^a   Choi, Yongwon ^d   Walsh, Matthew C ^d   Alexandropoulos, Konstantina ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Medicine/Liver Diseases ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CONTROLLED STUDY; EPITHELIUM CELL; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMIC EPITHELIAL CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTINUCLEAR; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLASMA CELLS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84881257767     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65414     Document Type: Article

References (64)

1. Nitta T, Murata S, Ueno T, Tanaka K, Takahama Y. Thymic microenvironments for T-cell repertoire formation. Adv Immunol. 2008;99:59-94.
2. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009;9(12):833-844.
3. Anderson MS, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298(5597):1395-1401.
4. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2001;2(11):1032-1039.
5. Tykocinski LO, Sinemus A, Kyewski B. The thymus medulla slowly yields its secrets. Ann N Y Acad Sci. 2008;1143:105-122.
6. Alexandropoulos K, Danzl NM. Thymic epithelial cells: antigen presenting cells that regulate T cell repertoire and tolerance development. Immunol Res. 2012;54(1-3):177-190.
7. Aschenbrenner K, et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol. 2007;8(4):351-358.
8. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002;3(8):756-763.
9. Jordan MS, et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist selfpeptide. Nat Immunol. 2001;2(4):301-306.
10. Irla M, Hollander G, Reith W. Control of central self-tolerance induction by autoreactive CD4+ thymocytes. Trends Immunol. 2010;31(2):71-79.
11. Burkly L, et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995;373(6514):531-536.
12. Akiyama T, et al. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science. 2005;308(5719):248-251.
13. Kajiura F, et al. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J Immunol. 2004;172(4):2067-2075.
14. Boehm T, Scheu S, Pfeffer K, Bleul CC. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J Exp Med. 2003;198(5):757-769.
15. Akiyama T, et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and selftolerance. Immunity. 2008;29(3):423-437.
16. Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009; 27:287-312.
17. Akirav EM, Ruddle NH, Herold KC. The role of AIRE in human autoimmune disease. Nat Rev Endocrinol. 2011;7(1):25-33.
18. Kobayashi T, et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity. 2003;19(3):353-363.
19. Gordon J, et al. Specific expression of lacZ and cre recombinase in fetal thymic epithelial cells by multiplex gene targeting at the Foxn1 locus. BMC Dev Biol. 2007;7:69.
20. Manley NR, Condie BG. Transcriptional regulation of thymus organogenesis and thymic epithelial cell differentiation. Prog Mol Biol Transl Sci. 2010;92:103-120.
21. Farr AG, Anderson SK. Epithelial heterogeneity in the murine thymus: fucose-specific lectins bind medullary epithelial cells. J Immunol. 1985;134(5):2971-2977.
22. Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med. 2007;204(11):2521-2528.
23. Rossi SW, et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med. 2007;204(6):1267-1272.
24. Danzl NM, Donlin LT, Alexandropoulos K. Regulation of medullary thymic epithelial cell differentiation and function by the signaling protein Sin. J Exp Med. 2010;207(5):999-1013.
25. Czaja AJ. Animal models of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2010;4(4):429-443.
26. Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol. 2011;8(6):320-329.
27. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354(1):54-66.
28. Homberg JC, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 1987;7(6):1333-1339.
29. Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988;8(6):1662-1666.
30. Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci. 2010; 55(8):2144-2161.
31. Baeres M, et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut. 2002;51(2):259-264.
32. Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen/ liver pancreas in variant autoimmune hepatitis. Autoimmunity. 2002;35(8):475-483.
33. Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97(2):413-419.
34. Kanzler S, et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol. 1999;31(4):635-640.
35. Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis. J Hepatol. 2000;33(2):208-215.
36. Krawitt EL. Discrimination of autoimmune hepatitis: autoantibody typing and beyond. J Gastroenterol. 2011;1:39-41.
37. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity. 2005; 23(2):227-239.
38. Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev. 2004;3(3):215-220.
39. Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 2007; 56(10):3459-3467.
40. Pahar B, Lackner AA, Veazey RS. Intestinal doublepositive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol. 2006;36(3):583-592.
41. Xie D, et al. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines. Cell Immunol. 2009;259(2):157-164.
42. Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139(1):58-72.e54.
43. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010;34(1):7-14.
44. Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev. 2005;4(5):315-321.
45. Derbinski J, Pinto S, Rosch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. Proc Natl Acad Sci U S A. 2008; 105(2):657-662.
46. King CG, et al. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med. 2006;12(9):1088-1092.
47. Peiseler M, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol. 2012;57(1):125-132.
48. Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol. 2012;4(1):22-28.
49. Zhou X, et al. Therapeutic potential of TGF-betainduced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity. 2011;44(1):43-50.
50. Calne RY, et al. Induction of immunological tolerance by porcine liver allografts. Nature. 1969; 223(5205):472-476.
51. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994;19(4):916-924.
52. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology. 1985; 55(3):369-389.
53. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3(1):51-62.
54. Hardtke-Wolenski M, Jaeckel E. Mouse models for experimental autoimmune hepatitis: limits and chances. Dig Dis. 2010;28(1):70-79.
55. Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut. 2004; 53(4):599-608.
56. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250-259.
57. Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis. 2002;22(4):353-364.
58. Ma Y, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002; 35(3):658-664.
59. Lankisch TO, Jaeckel E, Strassburg CP. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1. Semin Liver Dis. 2009;29(3):307-314.
60. Strassburg CP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2010;24(5):667-682.
61. Christen U, Hintermann E, Jaeckel E. New animal models for autoimmune hepatitis. Semin Liver Dis. 2009;29(3):262-272.
62. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372-374.
63. Ward SC, Schiano TD, Thung SN, Fiel MI. Plasma cell hepatitis in hepatitis C virus patients postliver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl. 2009;15(12):1826-1833.
64. Safadi R, et al. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 2004;127(3):870-882. Diseases Diseases Diseases